Longevity & Metabolic Health

Should You Be Using GLP-1s Proactively as a Longevity Drug?

GLP-1s are gaining indications beyond diabetes and obesity, but should healthy people use them proactively for longevity? Robin examines the evidence and what to do first.

A GLP-1 injection acting as a dimmer switch for appetite, metabolism, and the drive to engage with life.

More of my people are asking me to prescribe GLP-1s to optimize longevity, not to treat a disease — so this week I went deep on the research. Here’s my take.

GLP-1s just picked up their third and fourth FDA approvals this year — not for diabetes, not for obesity, but for sleep apnea and fatty liver disease. Heart disease got added the year before. At this rate, it's a fair question: is longevity next?

Robin's Short Version

  • GLP-1s now have uses beyond diabetes and weight loss, but nearly all human evidence still comes from people with obesity, metabolic dysfunction, or an existing diagnosis.
  • A new mouse study found a 12.4% increase in median lifespan with semaglutide, but calorie-matched mice lived just as long—suggesting reduced food intake may explain much of the effect.
  • For healthy people seeking longevity, proven priorities come first: build muscle, optimize body composition, eat enough protein and fiber, reduce inflammation, and limit alcohol.
  • If a GLP-1 still makes sense after those steps, treat it as a monitored experiment and track HbA1c, fasting insulin, fasting glucose, and body composition.
  • People who are already lean and metabolically healthy should be especially cautious, including watching for emotional flattening or reduced interest in food, sex, work, or life.

Here's what's driving that question for me lately. More and more of my patients asking about these drugs aren't sick. Their A1c is fine. They don't need to lose 50+ lbs. They want to optimize — shed the last 10, bring down visceral fat, tighten up their labs and their abs. No judgement, but, that’s a genuinely different use case than the one these drugs were built and tested for.

If "optimize, not treat" is the position you're in, that's exactly the kind of case we build a full metabolic picture for before anyone reaches for a prescription. Let's look at your labs →

Then, last week, a new mouse study on GLP-1s and lifespan landed, and the longevity world lost its mind a little. So let's dig into it: are GLP-1s truly a longevity drug?

⚡ Forward this protocol

⚡ Forward this protocol

Before you consider a GLP-1 for longevity — not diabetes, not obesity, not sleep apnea — do this first:

  • Strength train 2x/week, hit your protein target of 0.7 grams per pound of ideal body weight daily, and eat an anti-inflammatory diet that includes 1tbs of EVOO, under 25g added sugar, 30–50g fiber, a rainbow of produce every day
  • Cap alcohol with my 2-2-2 rule: no more than 2 nights/week, 2 drinks max per sitting, never 2 days in a row

👉 Forward this to the friend already asking you about Ozempic "for longevity."

What to know: the hype is ahead of the evidence — but not by as much as you'd think.

The old assumption: GLP-1s are diabetes and weight-loss drugs. Full stop.

The evidence outside diabetes and obesity is real.

These drugs now carry FDA approvals for obstructive sleep apnea, fatty liver disease, and heart disease — and there's compelling, if early, evidence they reduce alcohol cravings. Mood and mental health data are murkier: some people feel better, but some feel emotionally flatter and less interested in food, sex, or work.

This week's mouse study added fuel to the fire — but read the fine print.

A new Nature study1 found semaglutide extended median lifespan in aging female mice by 12.4% (834 vs. 742 days). But. the details matter: these were a single strain of genetically identical mice — the rodent version of testing a drug on 1,000+ identical humans, and we know that all humans aren’t identical. And in a separate side experiment, mice who simply matched the drug group's 24% calorie reduction lived just as long. So the raw lifespan number may be mostly about eating less. The untreated control mice in this study also lived just 742 days, shorter than many the usual cohorts of this strain, meaning this particular group of mice might have been an odd batch — worth keeping in mind before calling this a breakthrough.

The question isn't whether GLP-1s work. It's who they've been studied on.

Almost none of the evidence on GLP-1s comes from healthy people.

Every trial I just mentioned enrolled people who already had overweight, obesity, diabetes, or an existing diagnosis like sleep apnea, fatty liver disease, or heart disease. Take SELECT2, the landmark trial that showed a 20% drop in major cardiovascular events: it deliberately excluded people with diabetes — but everyone enrolled still had overweight or obesity plus established heart disease.

So, even the study built to isolate a "beyond diabetes" effect still only tells us about metabolically compromised people. We have real data on what GLP-1s do for sick and metabolically struggling people. We have almost no data on what they do for someone who's already relatively lean, fit, and metabolically healthy.

That gap is the actual answer to "should I take this for longevity."

What to do: how to answer "should I take this for longevity?"

1️⃣ Build muscle first — then check it on a full body DEXA.

Our metabolic health is largely in our control, if we build lean muscle mass and optimize body composition. This will have long-lasting and compounding effects on longevity that is proven today, not speculative.

  • Strength train each muscle group 2–3x/week: 3–5 sets, 60–85% of your one-rep max, 6–12 reps, stopping 1–2 reps shy of failure.
  • Hit your protein target — roughly 0.7g per lb of ideal body weight a day, with 25–35g per meal to trigger muscle protein synthesis.
  • Then get a DEXA and check your numbers against what I use with patients: lean mass target 70–75% (women) or 80–85% (men), and visceral fat under 1 lb (women) or 2 lbs (men). More on why muscle mass is the real longevity metric.

2️⃣ Lower your inflammation with fiber and fish.

Much of aging is driven by inflammation. We can lower inflammation by what we put in our mouths every day.

  • Get 1–2g combined EPA/DHA a day from fish oil, aiming for an omega-3 index of 8–11% — most people are far more deficient than they think (full breakdown, including why triglyceride-form fish oil matters and the AFib caveat above 1g/day, in my omega-3 newsletter). Keep added sugar under 25g a day.
  • Get 30–50g of fiber daily. Eat a genuine rainbow of fruits and vegetables — variety matters as much as volume.

3️⃣ Rein in alcohol (or eliminate it).

From sleep quality to cancer risk, alcohol is not our friend. Reduce your booze consumption for proven longevity benefits.

  • Follow my my 2-2-2 rule: no more than 2 nights a week, 2 drinks max per sitting, never 2 days in a row.

4️⃣ Still inflamed or carrying more weight than you'd like after 1 2 and 3?

  • Ok, now. Consider a GLP-1 — and treat it like an experiment, not a lifestyle. Track your HbA1c, fasting insulin, fasting glucose, and body composition along the way. You'll never know for certain if it added years to your life (you can't A/B test your own lifespan), but you can know exactly what it's doing to your biology.

5️⃣ Know when to walk away.

  • If you're already lean and metabolically healthy, this isn't your drug. And if you're on one and you are finding that your desire for food, sex, work, or life in general starts going flat — what I call the GLP-1 Robot Army effect — that's your body telling you to stop.

The goal: It’s not to decide if GLP-1s are good or bad, but to know exactly what problem you're using one to solve — and notice if it starts solving problems you never asked it to.

Living Longevity

Are all these longevity practices just the sprinkles on top of the ice cream sundae, or are they possibly the ice cream itself?

I've been thinking about this question a lot. Another way of asking it: is healthy living a nice-to-have, or the only thing to have?

In her 1926 essay On Being Ill, Virginia Woolf wrote: "Considering how common illness is, how tremendous the spiritual change that it brings, how astonishing, when the lights of health go down, the undiscovered countries that are then disclosed... it becomes strange indeed that illness has not taken its place with love, battle, and jealousy among the prime themes of literature."

For me, as I navigate a few life transitions — my youngest going to kindergarten and the "little kid era" officially being over, some changes at work (never a dull moment in startups!) — my health practices are, in fact, the thing keeping me stable and able to put one foot in front of the other. I'm not taking them for granted.

It sounds absurd when I list them out. Daily meditation, money and time spent eating well, sleeping 8 hours, drinking alcohol some but seldom, regular yoga, weight training, time in nature, therapy, coaching, guided psychedelic medicine, acupuncture, my supplement stack, even good old hydration (a bigger project than it should be for a consistently reluctant water drinker)... All of it seems like a lot. But I think, collectively, it's the only thing keeping me going.

We find our ability to cope with the ups and downs of life somewhere. Hopefully our coping mechanisms are sustainable and generative, rather than toxic or destructive. And when they are sustainable and generative, the compounding impact on the overall health and wealth of our lives is so much greater.

So maybe longevity isn't an obsession of the privileged, the bored, or the self-absorbed. Maybe its practices are the cornerstone of realizing our life's potential. And maybe we should treat it like the boots and pack we take on a long trek through the mountains — the necessary equipment for getting there, wherever "there" is for you.

One more thing...

If you're in the "should I optimize?" camp this newsletter is about, that's exactly the conversation Parsley Complete Care is built for — a clinician with the time to dig into your labs, your body composition, and your goals before anyone talks prescriptions. See how Complete Care works →

References

  1. Nature study on semaglutide and median lifespan in aging female mice, discussed above.
  2. SELECT trial of semaglutide and major cardiovascular events in adults with overweight or obesity and established cardiovascular disease, discussed above.
Originally published in the Off Script newsletter. Join Robin’s readers for weekly functional medicine insights.
As always, this newsletter is for informational and educational purposes only and is not intended as medical advice. Always consult your healthcare provider before making any health decisions or changes to your treatment plan.
The GLP-1 Longevity Question

See what the evidence actually says

Continue for Robin’s analysis of the lifespan research, who GLP-1s have actually been studied in, and the five steps she recommends before considering one for longevity.